Prof Christopher Sweeney

Professor Christopher Sweeney is the inaugural Director of the South Australian immunoGENomics CancerInstitute (SAIGENCI), Professor of Medicine at the University of Adelaide, andConsulting Medical Oncologist at the Royal Adelaide Hospital in Adelaide.

Prof Sweeney received hismedical degree from the University of Adelaide and completed an internship atthe Royal Adelaide Hospital. Prof Sweeney completed a fellowship inhematology/oncology and then joined the faculty at Indiana University MedicalCenter, Indiana, USA, and in 2009 moved to the Dana-Farber Cancer Institute andHarvard Medical School, Massachusetts, USA. He was promoted to Full Professorat Harvard University in 2018 and returned to Australia in 2022. Prof Sweeney wasawarded a Doctor of Health Sciences from the University of Adelaide in 2023 andFellowship of Australasian College of Physicians in 2024.

Prof Sweeney’s primary researchinterest is drug and biomarker discovery and development. His academic focus isprimarily on the management of genitourinary malignancies, with a focus onprostate and testicular cancer translational and clinical research.